.png)
Capillary Technologies India Ltd, a Bengaluru-based SaaS company, is tapping the primary market with its IPO worth ₹877.5 crore. The issue comprises a fresh issue of ₹345 crore and an offer for sale (OFS) of ₹532.5 crore by existing shareholders.
The IPO will open for subscription on November 14, 2025, and close on November 18, 2025. Shares are proposed to be listed on both BSE and NSE.
Price Band: ₹549 – ₹577
Issue Size: ₹877.5 Cr
Fresh Issue: ₹345 Cr
Offer for Sale (OFS): ₹532.5 Cr
Lot Size: 25 shares
Face Value: ₹2
Listing Date: November 21, 2025
Market Cap (Post-Issue): ₹4,576.09 Cr
Swastika Rating: Avoid
Founded in India, Capillary Technologies is a global SaaS player specializing in AI-based loyalty and customer engagement solutions. Its product suite includes:
The company serves over 410 brands across 47 countries, particularly in retail, BFSI, and hospitality sectors.
After two years of losses, Capillary turned profitable in FY25, posting a net profit of ₹14.15 crore. However, profitability remains modest, and the company’s valuation at nearly 299× P/E raises red flags for conservative investors.
✅ Market Leadership in Loyalty SaaS: Among Asia’s top loyalty and engagement solution providers.
✅ AI-Driven Personalization: Strong analytics capabilities improve brand–customer relationships.
✅ Global Reach: Presence in over 47 countries, with focus on retail and BFSI.
✅ Experienced Management: Deep domain expertise in enterprise technology and SaaS scalability.
⚠️ Aggressive Valuation: At nearly 299× earnings, the IPO appears significantly overvalued versus global peers like Salesforce (P/E ~40) and Adobe (P/E ~29).
⚠️ High OFS Component: Over 60% of the issue is Offer for Sale, meaning limited fresh capital infusion for business growth.
⚠️ Client Concentration: Heavy dependence on a few large enterprise clients could impact revenue stability.
⚠️ Tech Disruption Risk: Operating in a fast-evolving SaaS space demands continuous innovation and R&D spending.
⚠️ Global Competition: Faces stiff competition from Salesforce, Adobe, HubSpot, and others in international markets.
While Capillary Technologies has achieved a turnaround by reporting profits in FY25, the valuation premium is difficult to justify. With a modest 2.76% ROCE and limited domestic comparables, the IPO is priced much higher than global peers with stronger margins and balance sheets.
Swastika Investmart’s Outlook:
Given the aggressive pricing, high OFS component, and limited profitability track record, Swastika recommends Avoid for long-term investors. Short-term listing gains, if any, could be limited due to stretched valuations.
The IPO arrives at a time when India’s SaaS sector is gaining momentum globally, driven by demand for digital transformation and loyalty solutions. While this offers a long-term structural tailwind, investor appetite remains selective—focusing on companies with consistent profitability and scalable margins.
For instance, past SaaS listings like Freshworks witnessed post-listing volatility despite global brand presence—highlighting how profitability remains the key valuation driver.
If you are a risk-averse or conservative investor, this IPO might not fit your profile. The company’s profitability turnaround is still nascent, and with a major OFS, the proceeds largely benefit existing shareholders.
However, if you have a high-risk appetite and long-term faith in India’s SaaS growth, you may consider tracking the stock post-listing for potential entry opportunities at lower valuations.
Q1. What are the Capillary Technologies IPO dates?
The IPO opens on November 14, 2025, and closes on November 18, 2025.
Q2. What is the IPO price band and lot size?
The price band is ₹549–₹577 per share, and the lot size is 25 shares.
Q3. What is Swastika Investmart’s recommendation on the Capillary Technologies IPO?
Swastika has rated the IPO as Avoid due to its high valuation and limited profit history.
Q4. How does Capillary compare with global peers like Salesforce or Adobe?
Capillary’s P/E ratio (~299×) is far higher than global SaaS leaders like Salesforce (40×) or Adobe (29×), making it relatively overvalued.
Q5. What will Capillary use its IPO proceeds for?
Funds will go toward product R&D, cloud infrastructure, and system upgrades.
Capillary Technologies has demonstrated operational turnaround and solid market positioning in the loyalty SaaS segment. However, valuation comfort remains a concern, making the IPO suitable only for investors with high-risk tolerance.
For investors seeking balanced and research-driven decisions, Swastika Investmart offers SEBI-registered advisory, advanced research tools, and 24×7 support to help you navigate India’s IPO and equity landscape confidently.


Trust Our Expert Picks
for Your Investments!



